Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review.
Dorte Lisbet NielsenJesper Andreas PalshofNils BrünnerJan StenvangBirgitte Martine ViuffPublished in: International journal of molecular sciences (2017)
The biological role of ABCG2 in predicting clinical irinotecan sensitivity/resistance in CRC is uncertain. In particular, the significance of ABCG2 cellular localization needs to be established. Data concerning ABCG2 mRNA expression and prediction of adjuvant irinotecan efficacy are still sparse and need to be confirmed.